Medicare Enrolled

Dr. David Hallegua, M.D.

Rheumatology · Beverly Hills, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8641 WILSHIRE BOULEVARD, Beverly Hills, CA 90211
3106520928
In practice since 2005 (20 years)
NPI: 1063416964 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hallegua from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hallegua? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hallegua

Dr. David Hallegua is a rheumatology specialist in Beverly Hills, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hallegua performed 5,203 Medicare services across 1,222 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hallegua received a total of $22,168 from 49 pharmaceutical and/or device companies across 1038 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hallegua is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 27% volume in CA $22,168 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,203
Medicare services
Top 27% in CA for rheumatology
1,222
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~260 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,920 $18 $30
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
933 $1 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
734 $99 $547
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
350 $71 $449
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
142 $12 $60
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
135 $75 $225
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
103 $47 $350
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
93 $1 $45
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
91 $120 $300
Trigger point injection, 1-2 muscles
A procedure involving the injection of medication into one or two specific muscles to treat trigger points.
72 $36 $124
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
72 $8 $15
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
72 $44 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
72 $132 $550
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
70 $6 $100
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
66 $12 $75
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
56 $47 $171
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
47 $64 $190
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
41 $42 $149
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
32 $1 $40
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
27 $11 $125
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
22 $39 $145
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
19 $34 $150
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
17 $59 $200
Injection, methylprednisolone acetate, 40 mg 17 $6 $12
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.9% high complexity
67.4% medium
28.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$22,168
Total received (2018-2024)
Avg $3,167/year across 7 years
Top 16% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
1,038
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,059 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$109 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,144
2023
$3,415
2022
$3,716
2021
$2,847
2020
$1,890
2019
$3,436
2018
$3,720

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$722
Amgen Inc.
$561
Novartis Pharmaceuticals Corporation
$401
PFIZER INC.
$231
GlaxoSmithKline, LLC.
$220
Radius Health, Inc.
$220
Alvogen Inc
$163
Mallinckrodt Hospital Products Inc.
$127
Janssen Biotech, Inc.
$109
Fresenius Kabi USA, LLC
$83
AstraZeneca Pharmaceuticals LP
$58
Octapharma USA, Inc.
$55
Phathom Pharmaceuticals, Inc.
$50
Lilly USA, LLC
$32
Zimmer Biomet Holdings, Inc.
$29
Kiniksa Pharmaceuticals International, plc
$25
Aurinia Pharma U.S., Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Acella Pharmaceuticals, LLC
$15
Top 3 companies account for 53.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$4,780
Novartis Pharmaceuticals Corporation
$2,186
PFIZER INC.
$1,798
Janssen Biotech, Inc.
$1,399
ABBVIE INC.
$1,392
GlaxoSmithKline, LLC.
$1,391
Radius Health, Inc.
$1,177
Lilly USA, LLC
$1,086
Horizon Therapeutics plc
$891
Celgene Corporation
$609
AstraZeneca Pharmaceuticals LP
$575
AbbVie, Inc.
$567
GENZYME CORPORATION
$505
Mallinckrodt Hospital Products Inc.
$414
AbbVie Inc.
$394
Genentech USA, Inc.
$365
Aurinia Pharma U.S., Inc.
$338
Alexion Pharmaceuticals, Inc.
$326
Alvogen Inc
$233
Ultragenyx Pharmaceutical Inc.
$230
Nestle HealthCare Nutrition Inc.
$189
Fresenius Kabi USA, LLC
$179
Boehringer Ingelheim Pharmaceuticals, Inc.
$131
Janssen Scientific Affairs, LLC
$103
Biohaven Pharmaceuticals, Inc.
$68
Collegium Pharmaceutical, Inc.
$66
Biohaven Pharmaceutical Holding Company Ltd.
$61
Mallinckrodt Enterprises LLC
$59
Octapharma USA, Inc.
$55
Phathom Pharmaceuticals, Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$47
Horizon Pharma plc
$47
Zimmer Biomet Holdings, Inc.
$42
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$41
Gilead Sciences, Inc.
$37
Regeneron Healthcare Solutions, Inc.
$37
IBSA Pharma Inc.
$35
NESTLE HEALTHCARE NUTRITION INC.
$33
Dompe US, Inc.
$29
Kowa Pharmaceuticals America, Inc.
$29
Fidia Pharma USA Inc.
$26
Kiniksa Pharmaceuticals International, plc
$25
ANI Pharmaceuticals, Inc.
$23
Exact Sciences Corporation
$20
Teva Pharmaceuticals USA, Inc.
$19
Daiichi Sankyo Inc.
$19
Allergan Inc.
$17
Acella Pharmaceuticals, LLC
$15
Purdue Pharma L.P.
$12
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMJEVITA · AVSOLA · Actemra · Aimovig · Arcalyst · BENLYSTA · CERDELGA · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · COSENTYX · CYLTEZO · Cologuard Collection Kit · Crysvita · Cryvista · DUPIXENT · EUCRISA · EVENITY · Enbrel · FORTEO · Gel-One Cross-linked Hyaluronate · HUMIRA · HYMOVIS · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · LICART · LINZESS · LUCEMYRA · LUPKYNIS · LYRICA · Livalo · Morphabond ER · NP Thyroid 60 · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OXERVATE · Otezla · PENNSAID · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · Prolia · QULIPTA · RAYOS · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SOLIRIS · STELARA · SYMPROIC · Sports Medicine Product Portfolio · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tirosint · Trintellix · Tymlos · UBRELVY · VOQUEZNA · XELJANZ · XENPOZYME · XTAMPZA · Xofluza · Xtampza ER · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Beverly Hills?
Compare rheumatologists in the Beverly Hills area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
203
Per 100K population
2.1
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hallegua is a clinical cardiology specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hallegua experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Hallegua performed 1,920 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hallegua receive payments from pharmaceutical companies?
Yes. Dr. Hallegua received a total of $22,168 from 49 companies across 1,038 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hallegua's costs compare to other rheumatologists in Beverly Hills?
Dr. Hallegua's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hallegua) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →